Quintiles Transnational Corp. has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.
The acquisition of Eidetics will strengthen Quintiles' core consulting offerings in the areas of product development, commercialization and market access. Quintiles is expanding its consulting practices to help its pharmaceutical, biotech and medical device clients navigate the complex business environment.
Eidetics has provided research-based market insights and data analytics to support business decision making in drug development and commercialization for the past 20 years and counts among its repeat clients 18 of the top 20 pharmaceutical companies. The transaction is contingent upon the completion of certain conditions of the purchase agreement.